While human prophylaxis dominates the RNA based vaccine market with 81.5% share in 2025, veterinary and agricultural applications are emerging as high-growth segments that align with One-Health objectives and sustainable food production imperatives. The veterinary RNA vaccine market is projected to grow at a 16.4% CAGR through 2035, driven by the need for rapid response capabilities against emerging animal pathogens that threaten livestock productivity and food security. RNA vaccines offer particular advantages in veterinary applications, including the ability to rapidly update sequences in response to pathogen evolution, reduced development timelines compared to conventional vaccines, and the potential for multivalent formulations that protect against multiple diseases simultaneously. Swine influenza, avian influenza, foot-and-mouth disease, and African swine fever represent priority targets for veterinary RNA vaccine development, with over 34 active candidates in preclinical and clinical evaluation as of 2025.

The agricultural sector is adopting RNA-based technologies for crop protection and pest management, with RNA interference (RNAi) and messenger RNA applications showing promise for controlling plant pathogens and insect pests. RNA Based Vaccine Market research indicates that RNA-based biocontrol products can be designed to target specific pest species without affecting beneficial organisms, offering an environmentally friendly alternative to chemical pesticides. Sprayable RNA formulations that induce RNAi in target insects are advancing through regulatory evaluation, with the potential to reduce crop losses while minimizing ecological disruption. Over 12 agricultural RNA technology programs were active in 2025, reflecting growing industry interest in sustainable crop protection solutions. The ability to rapidly design and produce RNA biocontrol agents in response to emerging pest threats provides agricultural systems with unprecedented flexibility in pest management strategies.

Aquaculture is increasingly adopting RNA vaccines to protect farmed fish against viral and bacterial pathogens, addressing the challenge of disease transmission in high-density farming environments. RNA vaccines for infectious salmon anemia, viral hemorrhagic septicemia, and streptococcal infections are in various stages of development, with the potential to reduce antibiotic usage in aquaculture and improve fish health outcomes. The One-Health approach recognizes the interconnectedness of human, animal, and environmental health, and RNA-based technologies are uniquely positioned to address this paradigm across multiple domains. By reducing antibiotic usage in livestock and aquaculture, enabling rapid response to zoonotic disease threats, and providing sustainable crop protection, RNA technologies contribute to antimicrobial stewardship and food security objectives. The integration of RNA vaccines into comprehensive animal health programs, supported by advances in delivery technology and cost-effective manufacturing, is creating new market opportunities that extend beyond human medicine. As regulatory frameworks for veterinary RNA products mature and as agricultural industries prioritize sustainable practices, the non-human segments of the RNA vaccine market are poised to capture an increasing share of total industry revenue and contribute to global food system resilience.

Q1: How fast is the veterinary RNA vaccine segment growing? The veterinary RNA vaccine market is projected to grow at 16.4% CAGR through 2035, with over 34 active candidates targeting swine flu, avian flu, and foot-and-mouth disease.

Q2: What agricultural applications exist for RNA technology? RNA interference (RNAi) biocontrol products target specific pests and pathogens in crops, offering environmentally friendly alternatives to chemical pesticides with 12 active programs in 2025.

Q3: How do RNA vaccines support sustainable aquaculture? RNA vaccines protect farmed fish against viral and bacterial pathogens, reducing antibiotic usage and improving health outcomes in high-density farming environments